Mechlorethamine
Showing 1 - 25 of 88
Cutaneous T-Cell Lymphoma/Mycosis Fungoides Trial in Fairport (Hypericin, Mechlorethamine Topical Gel)
Not yet recruiting
- Cutaneous T-Cell Lymphoma/Mycosis Fungoides
- Hypericin
- Mechlorethamine Topical Gel
-
Fairport, New YorkRochester Skin Lymphoma Medical Group
Nov 20, 2023
Hodgkin's Lymphoma Trial in Milano (ITF2357)
Completed
- Hodgkin's Lymphoma
-
Milano, ItalyIstituto Nazionale per la Cura e lo Studio dei Tumori
Apr 20, 2021
Skin Irritation Trial in Cleveland (4 , 4 Vitamin D, Valchlor)
Completed
- Skin Irritation
- 4 placebo
- +2 more
-
Cleveland, OhioUniversity Hospitals
Dec 6, 2021
Lichen Planopilaris Trial in Jacksonville (Mechlorethamine 0.016% Top Gel)
Completed
- Lichen Planopilaris
- Mechlorethamine 0.016% Top Gel
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 26, 2021
Lymphoma Trial (biological, drug, radiation)
Active, not recruiting
- Lymphoma
- bleomycin sulfate
- +7 more
- (no location specified)
Feb 2, 2021
Lymphoma Trial in Stanford (Bleomycin sulfate, Stanford V regimen, Doxorubicin HCl)
Completed
- Lymphoma
- Bleomycin sulfate
- +7 more
-
Stanford, CaliforniaStanford Cancer Center at Stanford University Medical Center
Aug 10, 2020
Plasma Cell Myeloma Trial in Omaha (drug, procedure, biological)
Active, not recruiting
- Plasma Cell Myeloma
- Melphalan
- +4 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Nov 21, 2022
Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB) Trial in Bordeaux, Paris (chlormethine gel)
Recruiting
- Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB)
- chlormethine gel
-
Bordeaux, France
- +1 more
Aug 17, 2022
Lymphoma Trial in Worldwide (biological, drug, radiation)
Unknown status
- Lymphoma
- bleomycin sulfate
- +9 more
-
Antwerp, Belgium
- +55 more
Feb 2, 2021
Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6
Withdrawn
- Recurrent Diffuse Large B-Cell Lymphoma
- +9 more
- Autologous Hematopoietic Stem Cell Transplantation
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 11, 2023
Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)
Recruiting
- Plasma Cell Myeloma
- Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 27, 2022
Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, other, radiation)
Active, not recruiting
- Primary Myelofibrosis
- Secondary Myelofibrosis
- Allogeneic Hematopoietic Stem Cell Transplantation
- +11 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 10, 2023
CTCL Trial in New York (StrataCTX® gel)
Recruiting
- CTCL
- StrataCTX® gel
-
New York, New YorkColumbia University Medical Center, Department of Dermatology
Aug 3, 2021
Mycosis Fungoides of Skin (Diagnosis), Cutaneous T-cell Lymphoma, Non Hodgkin Lymphoma Trial in Cleveland (Med-Jet Injector,
Not yet recruiting
- Mycosis Fungoides of Skin (Diagnosis)
- +5 more
- Med-Jet Injector
- +4 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 17, 2023
Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Houston (procedure, biological, other, drug)
Active, not recruiting
- Plasma Cell Leukemia
- Plasma Cell Myeloma
- Autologous Hematopoietic Stem Cell Transplantation
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune Trial in Denver, Seattle (biological,
Recruiting
- Autoimmune Disease
- +18 more
- Anti-Thymocyte Globulin
- +9 more
-
Denver, Colorado
- +2 more
Feb 1, 2023
Sulforaphane Bioavailability Trial in Kannapolis (Broccoli seed extract, Broccoli seed extract with mustard seed powder)
Completed
- Sulforaphane Bioavailability
- Broccoli seed extract
- Broccoli seed extract with mustard seed powder
-
Kannapolis, North CarolinaAppalachian State University Human Performance Lab, North Caroli
Jan 23, 2023
Recurrent DLBCL, Recurrent T-Cell Non-Hodgkin Lymphoma, Refractory DLBCL Trial in Houston (drug, procedure, other, biological)
Recruiting
- Recurrent Diffuse Large B-Cell Lymphoma
- +4 more
- Busulfan
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, biological, drug,
Recruiting
- Acute Lymphoblastic Leukemia
- +3 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 12, 2023
Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal
Active, not recruiting
- Platinum-Resistant Fallopian Tube Carcinoma
- +11 more
- Aldesleukin
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 13, 2022
Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor, CNS Germ Cell Tumor Trial in Houston (drug, procedure, biological)
Recruiting
- Anaplastic Ependymoma
- +14 more
- Etoposide
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Aug 17, 2022
Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome Trial in Duarte (Fludarabine, Itacitinib Adipate,
Active, not recruiting
- Acute Leukemia
- +4 more
- Fludarabine
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, radiation)
Recruiting
- Primary Myelofibrosis
- Secondary Myelofibrosis
- Allogeneic Hematopoietic Stem Cell Transplantation
- +9 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 21, 2022
Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)
Active, not recruiting
- Plasma Cell Leukemia
- +3 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 6, 2022